Tag: lantus

Pressmeddelanden

Sanofi Inaugurates Lantus® SoloSTAR® Pen Assembly Plant in its Beijing Facility - The Group Pledges Continuous Commitment to Diabetes Management in China

2012-05-29 17:04 Sanofi Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the inauguration of a new assembling and packaging line to produce its flagship pre-filled insulin injection pen Lantus® SoloSTAR® at its Beijing plant located at the Beijing Economic-Technological Development Area (BDA).

Once-Daily Lixisenatide in Combination with Basal Insulin Demonstrates Significant Improvement in Glucose Control

2010-09-30 10:57 Sanofi Sanofi-aventis announced today the top-line results of the GETGOAL-L-ASIA study assessing the efficacy and safety of lixisenatide, a once-daily GLP-1 receptor agonist, in combination with basal insulin.

Lägre doser Lantus krävs för att nå blodsockermål jämfört med insulin detemir

2009-10-01 10:49 Sanofi Sanofi-aventis tillkännagav nyligen resultaten av en jämförande studie som ger ytterligare bevis för den goda effekten av 24-timmars basinsulinet Lantus (insulin glargin) en gång om dagen i jämförelse med insulin detemir två gånger om dagen.